DRTX

Durata Therapeutics, Inc. News Headlines

$16.77
*  
0.39
2.38%
Get DRTX Alerts
*Delayed - data as of Aug. 26, 2014  -  Find a broker to begin trading DRTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DRTX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

5 Stocks Moving on Unusual Volume
8/19/2014 7:00:00 AM - TheStreet

Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha

What Makes Durata Therapeutics (DRTX) a Strong Sell? - Tale of the Tape
8/13/2014 8:44:04 AM - Zacks.com

BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX
8/7/2014 12:50:00 AM - RTT News

Durata Therapeutics (DRTX) Worth Watching: Stock Gains 18.5% - Tale of the Tape
8/5/2014 9:46:00 AM - Zacks.com

CytoDyn On Watch List, FDA Panel Snubs EDAP, CRY Makes Investors Smile
7/31/2014 12:32:00 AM - RTT News

United Therapeutics (UTHR) Jumps: Stock Adds 8.1% in Session - Tale of the Tape
7/30/2014 8:37:00 AM - Zacks.com

Commit To Buy Durata Therapeutics At $15, Earn 24.6% Annualized Using Options
7/3/2014 11:48:22 AM - BNK Invest

Cubist Gains FDA Approval for Sivextro - Analyst Blog
6/23/2014 11:50:00 AM - Zacks.com

Durata Therapeutics' Skin Drug Gets FDA Nod - Analyst Blog
5/27/2014 4:30:00 PM - Zacks.com

Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha

Sector Update: Healthcare Stocks Higher Pre-Market; Durata Sinks 11% After Strong Rally
5/27/2014 8:59:49 AM - MT Newswires

Sector Update: Healthcare
5/27/2014 8:57:38 AM - MT Newswires

Sector Update: Healthcare Shares Mixed Pre-Market; Durata up 2.4% on Buy Rating at MLV
5/23/2014 8:33:43 AM - MT Newswires

Sector Update: Healthcare
5/23/2014 8:32:04 AM - MT Newswires

Insider Bets Paying Off At DRTX As New 52-Week High Reached
5/20/2014 1:06:51 PM - BNK Invest

What's Next For Durata?
5/16/2014 11:08:00 AM - Seeking Alpha

Durata (DRTX) is in Overbought Territory: What's Next? - Tale of the Tape
5/13/2014 11:42:16 AM - Zacks.com

Durata Therapeutics: Approval Probability And Investment Strategy For Dalbavancin
5/5/2014 11:56:00 AM - Seeking Alpha

Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix
4/25/2014 10:34:00 AM - Seeking Alpha

Over 91% Chance Of Approval For MannKind And Durata Therapeutics
4/7/2014 12:00:00 PM - Seeking Alpha

Durata Therapeutics: Gains Ahead
4/2/2014 9:05:00 AM - Seeking Alpha

Durata Therapeutics (DRTX) Jumps: Stock Rises 6.5% - Tale of the Tape
2/19/2014 10:21:01 AM - Zacks.com

Durata Therapeutics: Primed For Big Gains With March Advisory Committee Date Announced
2/13/2014 11:22:00 AM - Seeking Alpha

Antibiotic Companies To Cash In On In 2014
2/13/2014 8:30:00 AM - Seeking Alpha